Doctor profile · Federal record
Dr. Emily Langlinais, PA-C
Physician Assistant · Lafayette, LA
- NPI 1134845662
- Accepts Medicare
- MIPS 97.4 / 100 · 2023
- 4 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
101 Rue Fontaine Bldg 1
Lafayette, LA 705085744
(337) 524-1700
fax (337) 524-1702
Credentials & registration
- NPI registered
- October 2022 — 4 yrs on file
- Year of graduation
- 2022 — 4 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Louisiana #333913
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134845662. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,230
Distinct HCPCS
10
Medicare allowed
$63,673
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 376 | 87 | $5 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 189 | 150 | $102 | |
17110 |
Destruction of skin growth, 1-14 growths | 169 | 153 | $87 | |
17000 |
Destruction of precancer skin growth, 1 growth | 159 | 147 | $41 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 115 | 110 | $72 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 88 | 86 | $45 | |
11102 |
Biopsy of related skin growth, first growth | 37 | 36 | $72 | |
17111 |
Destruction of skin growth, 15 or more growths | 33 | 31 | $103 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | 21 | $1 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 18 | 18 | $132 |
In context: peer comparison
Among 28 peers in Lafayette Physician Assistant, average services per provider: 120. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$1,501
Transactions
65
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 18 | $346.08 | |
| Arcutis Biotherapeutics, INC. | 4 | $278.38 | |
| Lilly USA, LLC | 8 | $157.88 | |
| Genzyme Corporation | 4 | $96.94 | |
| Regeneron Healthcare Solutions, INC. | 4 | $84.74 | |
| Amgen INC. | 4 | $78.90 | |
| Incyte Corporation | 4 | $71.64 | |
| Sun Pharmaceutical Industries INC. | 3 | $64.73 | |
| Leo Pharma INC. | 4 | $64.22 | |
| Janssen Biotech, INC. | 3 | $62.23 | |
| Galderma Laboratories, L.P. | 3 | $43.65 | |
| Mallinckrodt Hospital Products INC. | 1 | $36.93 | |
| Dermavant Sciences, INC. | 2 | $30.19 | |
| Ucb, INC. | 2 | $29.41 | |
| Medimetriks Pharmaceuticals, INC. | 1 | $20.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
412
Patients
259
Total drug cost
$12,034
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 98 | 54 | $2,677 |
| Hydrocortisone | Generic | 69 | 52 | $371 |
| Triamcinolone Acetonide | Generic | 58 | 49 | $774 |
| Doxycycline Hyclate | Generic | 38 | 26 | $1,544 |
| Clobetasol Propionate | Generic | 29 | 26 | $1,972 |
| Fluocinonide | Generic | 29 | 18 | $1,853 |
| Mupirocin | Generic | 23 | 22 | $256 |
| Levocetirizine Dihydrochloride | Generic | 18 | 0 | $250 |
| Fluconazole | Generic | 15 | 0 | $142 |
| Betamethasone Dipropionate | Generic | 13 | 12 | $800 |
Frequently asked questions
What is Dr. Emily Langlinais's medical specialty?
Dr. Emily Langlinais practices Physician Assistant in Lafayette, LA.
Where does Dr. Emily Langlinais practice?
Dr. Emily Langlinais practices at 101 Rue Fontaine Bldg 1, Lafayette, LA 705085744. Office phone: 3375241700.
What is Dr. Emily Langlinais's NPI?
Dr. Emily Langlinais's National Provider Identifier (NPI) is 1134845662, issued by NPPES.
Does Dr. Emily Langlinais accept Medicare assignment?
Yes. Dr. Emily Langlinais accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Emily Langlinais commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.